Ensysce Biosciences, Inc. (ENSC) stock forecast and price target
Price $0.42 · data as of November 13, 2026
12-month price target
Average target$4.08
Upside / downside+875.9%
Analysts3
ConsensusStrong buy
Low $2.00Average $4.08High $8.25
Gold marker: average target · white marker: today’s price ($0.42)
Analyst ratings
Strong buy 0Buy 2Hold 0Sell 0Strong sell 0
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $-0.23 | — | $5M |
| Next fiscal year ends December 31, 2027 | $-0.05 | +76.0% | $3M |
| Next quarter ends December 31, 2026 | $-0.02 | — | $1M |
| Quarter after ends March 31, 2027 | $-0.01 | — | $2M |
Consensus of the analysts covering Ensysce Biosciences, updated daily.
Frequently asked questions
What is the Ensysce Biosciences stock price target?
The average 12-month target from 3 analysts is $4.08, 875.9% above the current price of $0.42 Targets range from $2.00 to $8.25.
Is Ensysce Biosciences a buy according to analysts?
The consensus rating is “Strong buy” (2 buy). Ratings are opinions, not guarantees; this is not investment advice.
How much is Ensysce Biosciences expected to earn?
Analysts expect EPS of $-0.23 for the fiscal year ending December 31, 2026 and $-0.05 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.